Substituted Carbinol Compound

Abstract

Disclosed is a novel LXRß agonist which is useful as a prophylactic and/or therapeutic agent for arteriosclerosis including atherosclerosis and arteriosclerosis induced by diabetes, hyperlipemia, hypercholesterolemia, a fat-related disease, an inflammatory disease which is a disease induced by an inflammatory cytokine, a skin disease such as allergic skin disease, diabetes or Alzheimer's disease. Specifically disclosed is a carbinol derivative represented by the general formula (1), a salt thereof, or a solvate of the derivative or the salt.


Claims

Information currently unavailable.

IPC Classifications

Download Citation


Sign in to the Lens

Feedback